# Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

> **NCT01720251** · PHASE2 · COMPLETED · sponsor: **Anergis** · enrollment: 240 (actual)

## Conditions studied

- Allergic Rhinitis
- Rhinoconjunctivitis

## Interventions

- **DRUG:** placebo
- **DRUG:** AllerT low dose
- **DRUG:** AllerT full dose

## Key facts

- **NCT ID:** NCT01720251
- **Lead sponsor:** Anergis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720251, "Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01720251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*